Answers are grounded in this paper and cite their sources.
A reliable diagnosis of amyloidosis is usually based on a tissue biopsy. With increasing options for specific treatments of the different amyloid diseases, an exact and valid diagnosis including determination of the biochemical fibril nature is imperative. Biopsy sites as well as amyloid typing principles vary and this paper describes methods employed at some laboratories specialised in amyloidosis in Europe, Japan and USA.
No takes yet. Share an insight, caveat, or question.
Benson et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: